Literature DB >> 15802934

Long-term patient satisfaction of external dacryocystorhinostomy.

K Mansour1, M Sere, A G Oey, K J Bruin, L J Blanksma.   

Abstract

PURPOSE: To evaluate patient's opinion on the long-term success of external dacryocystorhinostomy using the same quantitative parameter pre- and postoperatively.
METHODS: A postal questionnaire was sent to 139 patients who had undergone external dacryocystorhinostomy. The only parameter for success of the treatment was the improvement of patient's subjective pre- and postoperative symptoms score. The duration of this follow-up ranged from 1 year up to 5 years postoperatively. Statistical analyses were performed using the Wilcoxon Signed-Ranks test and the chi2 test.
RESULTS: According to the patient's own evaluation, external dacryocystorhinostomy is a successful operation. After 1 year the success percentage was 89%, after 2-3 years it was 79% and after 4-5 years it was 71%.
CONCLUSION: External dacryocystorhinostomy is appreciated by the patients and considered a successful operation. The subjective evaluation of this operation should yield more creditability than objective methods. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15802934     DOI: 10.1159/000083268

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  3 in total

1.  Symptom assessment in patients with functional and primary acquired nasolacrimal duct obstruction before and after successful dacryocystorhinostomy surgery: a prospective study.

Authors:  L M Cheung; I C Francis; F Stapleton; G Wilcsek
Journal:  Br J Ophthalmol       Date:  2007-06-21       Impact factor: 4.638

2.  Long-Term Results in Transcanalicular Laser and External Dacryocystorhinostomy.

Authors:  Halil Ibrahim Yener; Muammer Ozcimen
Journal:  Beyoglu Eye J       Date:  2020-02-17

3.  Outcomes of External Dacryocystorhinostomy under General and Local Anesthetics in a Tertiary Clinic.

Authors:  Hasan Aytogan; Mehmet Ali Doran; Emre Ayintap
Journal:  Beyoglu Eye J       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.